Everything You Should Know About Jeanmarie Guenot’s Cancer Research Through Amphivena Therapeutics

 

Jeanmarie Guenot has been in the pharmaceutical industry for over 20 years. She has held various positions in the biotechnology and pharmaceutical industry. She has worked with both private and public corporations in areas of business development, project and alliance management, venture capital, and research and development. She is well versed in the process of rebuilding and building corporations. Jeanmarie Guenot currently holds the position of CEO at Amphivena Therapeutics, Inc. The company is mainly focused on the area of bifunctional antibody therapies to aid with hematologic malignancies.

Before she took on her current position, LinkedIn credits that Dr. Guenot was running a startup known as SKS Ocular. The ophthalmic company incubator was focused on glaucoma therapeutics, ocular drug delivery technology, ocular inflammation, macular degeneration, and dry AMD. She had also held the position of VP in charge of Corporate & Business Development at PDL BioPharma. At the company, she was in charge of mergers and acquisitions, licensing, and alliance management for R&D.

The transaction, which was worth $800 million, involved a $100 million investment in PDL. During her time at PDL, she also helped to negotiate the licensing of ophthalmic indication for an oncology drug to Ophthotech. Jeanmarie Guenot has vast experience in the areas of cardiovascular diseases, neurology, autoimmune diseases, and neurology.

Jeanmarie Guenot started her successful career at Atlas Venture. She was in charge of managing venture capital investments. She also helped to build a number of life science companies. Her scientific career began when she joined Preclinical R&D at Hoffmann- La Roche. Her job entailed the discovery and development of drugs for inflammation, autoimmune illnesses, oncology, and metabolic disorders. She trained in medical and physical chemistry. Her area of focus was semi-empirical methods for molecular dynamics, X-ray, drug design, and NMR refinement. Dr. Guenot earned her Ph.D. from the University of California. Her MBA was earned from the Wharton school of finance of the University of Pennsylvania.

Jeanmarie has a lot of experience in the management of large companies. Her commitment to professionalism, integrity and hard work ensure that will continue to enjoy lots of success in coming years. Read her work on PubFacts, and be sure to follow Jeanmarie Guenot for yourself via Facebook.

One thought on “Everything You Should Know About Jeanmarie Guenot’s Cancer Research Through Amphivena Therapeutics

Comments are closed.